Compare PLSE & SGRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | SGRY |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2015 | 2015 |
| Metric | PLSE | SGRY |
|---|---|---|
| Price | $25.51 | $14.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | $22.00 | ★ $22.25 |
| AVG Volume (30 Days) | 265.5K | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.14 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,145,438,000.00 |
| Revenue This Year | $840.00 | $5.09 |
| Revenue Next Year | $287.54 | $5.67 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.56 | $11.41 |
| 52 Week High | $28.53 | $24.10 |
| Indicator | PLSE | SGRY |
|---|---|---|
| Relative Strength Index (RSI) | 53.19 | 55.12 |
| Support Level | $23.60 | $13.29 |
| Resistance Level | $27.60 | $14.94 |
| Average True Range (ATR) | 1.85 | 0.50 |
| MACD | -0.14 | 0.08 |
| Stochastic Oscillator | 39.25 | 57.27 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.